A NIMS research team has developed an automated high-throughput system capable of generating datasets from a single sample of ...
Get key insights from Insight Molecular Diagnostics' Q3 2025 earnings call—FDA progress, $1B market outlook, and innovations in transplant testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback